JP2020505187A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2020505187A5 JP2020505187A5 JP2019555530A JP2019555530A JP2020505187A5 JP 2020505187 A5 JP2020505187 A5 JP 2020505187A5 JP 2019555530 A JP2019555530 A JP 2019555530A JP 2019555530 A JP2019555530 A JP 2019555530A JP 2020505187 A5 JP2020505187 A5 JP 2020505187A5
- Authority
- JP
- Japan
- Prior art keywords
- drainage tube
- layer
- drainage
- outer layer
- coating
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000000576 coating method Methods 0.000 claims description 27
- 239000011248 coating agent Substances 0.000 claims description 25
- 230000000975 bioactive effect Effects 0.000 claims description 5
- 239000010410 layer Substances 0.000 description 80
- 239000000463 material Substances 0.000 description 35
- 239000000560 biocompatible material Substances 0.000 description 16
- 230000002209 hydrophobic effect Effects 0.000 description 15
- 210000000941 bile Anatomy 0.000 description 13
- 229920002635 polyurethane Polymers 0.000 description 11
- 239000004814 polyurethane Substances 0.000 description 11
- 206010061218 Inflammation Diseases 0.000 description 10
- 210000000013 bile duct Anatomy 0.000 description 10
- 230000004054 inflammatory process Effects 0.000 description 10
- 210000003205 muscle Anatomy 0.000 description 10
- PYVHTIWHNXTVPF-UHFFFAOYSA-N F.F.F.F.C=C Chemical compound F.F.F.F.C=C PYVHTIWHNXTVPF-UHFFFAOYSA-N 0.000 description 9
- 238000007459 endoscopic retrograde cholangiopancreatography Methods 0.000 description 9
- 210000001519 tissue Anatomy 0.000 description 9
- 230000003387 muscular Effects 0.000 description 8
- 229920005989 resin Polymers 0.000 description 8
- 239000011347 resin Substances 0.000 description 8
- 238000003780 insertion Methods 0.000 description 7
- 230000037431 insertion Effects 0.000 description 7
- 229910001220 stainless steel Inorganic materials 0.000 description 7
- 238000001356 surgical procedure Methods 0.000 description 7
- 229920006026 co-polymeric resin Polymers 0.000 description 5
- 238000000034 method Methods 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- 239000004952 Polyamide Substances 0.000 description 4
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 4
- 238000001839 endoscopy Methods 0.000 description 4
- HCDGVLDPFQMKDK-UHFFFAOYSA-N hexafluoropropylene Chemical compound FC(F)=C(F)C(F)(F)F HCDGVLDPFQMKDK-UHFFFAOYSA-N 0.000 description 4
- 229920003023 plastic Polymers 0.000 description 4
- 239000004033 plastic Substances 0.000 description 4
- 229920002647 polyamide Polymers 0.000 description 4
- -1 polyethylene Polymers 0.000 description 4
- 239000000741 silica gel Substances 0.000 description 4
- 229910002027 silica gel Inorganic materials 0.000 description 4
- 239000004698 Polyethylene Substances 0.000 description 3
- 210000003445 biliary tract Anatomy 0.000 description 3
- 229920001577 copolymer Polymers 0.000 description 3
- 230000006378 damage Effects 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 229910052751 metal Inorganic materials 0.000 description 3
- 239000002184 metal Substances 0.000 description 3
- 229920000573 polyethylene Polymers 0.000 description 3
- 229920000642 polymer Polymers 0.000 description 3
- 229920000915 polyvinyl chloride Polymers 0.000 description 3
- 239000004800 polyvinyl chloride Substances 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 230000035755 proliferation Effects 0.000 description 3
- 230000001225 therapeutic effect Effects 0.000 description 3
- 229930189077 Rifamycin Natural products 0.000 description 2
- BLRPTPMANUNPDV-UHFFFAOYSA-N Silane Chemical compound [SiH4] BLRPTPMANUNPDV-UHFFFAOYSA-N 0.000 description 2
- 210000000683 abdominal cavity Anatomy 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 239000003242 anti bacterial agent Substances 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 230000036760 body temperature Effects 0.000 description 2
- 229920001971 elastomer Polymers 0.000 description 2
- 238000007463 endoscopic sphincterotomy Methods 0.000 description 2
- 238000002955 isolation Methods 0.000 description 2
- 229920000126 latex Polymers 0.000 description 2
- 239000004816 latex Substances 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 229960003292 rifamycin Drugs 0.000 description 2
- HJYYPODYNSCCOU-ODRIEIDWSA-N rifamycin SV Chemical compound OC1=C(C(O)=C2C)C3=C(O)C=C1NC(=O)\C(C)=C/C=C/[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@H](C)[C@@H](OC)\C=C\O[C@@]1(C)OC2=C3C1=O HJYYPODYNSCCOU-ODRIEIDWSA-N 0.000 description 2
- 229910000077 silane Inorganic materials 0.000 description 2
- 229920002379 silicone rubber Polymers 0.000 description 2
- 239000004945 silicone rubber Substances 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 239000010935 stainless steel Substances 0.000 description 2
- 239000002344 surface layer Substances 0.000 description 2
- MGSRCZKZVOBKFT-UHFFFAOYSA-N thymol Chemical compound CC(C)C1=CC=C(C)C=C1O MGSRCZKZVOBKFT-UHFFFAOYSA-N 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- WCDDVEOXEIYWFB-VXORFPGASA-N (2s,3s,4r,5r,6r)-3-[(2s,3r,5s,6r)-3-acetamido-5-hydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4,5,6-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@@H]1C[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](C(O)=O)O[C@@H](O)[C@H](O)[C@H]1O WCDDVEOXEIYWFB-VXORFPGASA-N 0.000 description 1
- BQCIDUSAKPWEOX-UHFFFAOYSA-N 1,1-Difluoroethene Chemical compound FC(F)=C BQCIDUSAKPWEOX-UHFFFAOYSA-N 0.000 description 1
- OPVBUKANCGEZEQ-UHFFFAOYSA-N 5-hydroxy-2-methylpent-2-enoic acid;styrene Chemical compound C=CC1=CC=CC=C1.OC(=O)C(C)=CCCO OPVBUKANCGEZEQ-UHFFFAOYSA-N 0.000 description 1
- 206010056375 Bile duct obstruction Diseases 0.000 description 1
- 206010051341 Bile duct stenosis Diseases 0.000 description 1
- 206010004637 Bile duct stone Diseases 0.000 description 1
- CHDVXKLFZBWKEN-UHFFFAOYSA-N C=C.F.F.F.Cl Chemical compound C=C.F.F.F.Cl CHDVXKLFZBWKEN-UHFFFAOYSA-N 0.000 description 1
- 206010008635 Cholestasis Diseases 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 229920000219 Ethylene vinyl alcohol Polymers 0.000 description 1
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 1
- CEAZRRDELHUEMR-URQXQFDESA-N Gentamicin Chemical compound O1[C@H](C(C)NC)CC[C@@H](N)[C@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](NC)[C@@](C)(O)CO2)O)[C@H](N)C[C@@H]1N CEAZRRDELHUEMR-URQXQFDESA-N 0.000 description 1
- 229930182566 Gentamicin Natural products 0.000 description 1
- 244000043261 Hevea brasiliensis Species 0.000 description 1
- 239000002033 PVDF binder Substances 0.000 description 1
- 208000016222 Pancreatic disease Diseases 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- 229920002125 Sokalan® Polymers 0.000 description 1
- 239000004809 Teflon Substances 0.000 description 1
- 229920006362 Teflon® Polymers 0.000 description 1
- 239000005844 Thymol Substances 0.000 description 1
- 238000005299 abrasion Methods 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 239000003146 anticoagulant agent Substances 0.000 description 1
- 229940027983 antiseptic and disinfectant quaternary ammonium compound Drugs 0.000 description 1
- 229960004676 antithrombotic agent Drugs 0.000 description 1
- 229960000686 benzalkonium chloride Drugs 0.000 description 1
- CADWTSSKOVRVJC-UHFFFAOYSA-N benzyl(dimethyl)azanium;chloride Chemical compound [Cl-].C[NH+](C)CC1=CC=CC=C1 CADWTSSKOVRVJC-UHFFFAOYSA-N 0.000 description 1
- 208000003167 cholangitis Diseases 0.000 description 1
- 238000002192 cholecystectomy Methods 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 230000007797 corrosion Effects 0.000 description 1
- 238000005260 corrosion Methods 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 210000002249 digestive system Anatomy 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000000806 elastomer Substances 0.000 description 1
- 229920006351 engineering plastic Polymers 0.000 description 1
- 229920001038 ethylene copolymer Polymers 0.000 description 1
- 229920000840 ethylene tetrafluoroethylene copolymer Polymers 0.000 description 1
- 239000010408 film Substances 0.000 description 1
- 229910052731 fluorine Inorganic materials 0.000 description 1
- 239000011737 fluorine Substances 0.000 description 1
- NBVXSUQYWXRMNV-UHFFFAOYSA-N fluoromethane Chemical compound FC NBVXSUQYWXRMNV-UHFFFAOYSA-N 0.000 description 1
- 229920002313 fluoropolymer Polymers 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 229960002518 gentamicin Drugs 0.000 description 1
- 238000009499 grossing Methods 0.000 description 1
- 230000002440 hepatic effect Effects 0.000 description 1
- 229940014041 hyaluronate Drugs 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- 239000000017 hydrogel Substances 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 238000009434 installation Methods 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 230000003211 malignant effect Effects 0.000 description 1
- 229920003052 natural elastomer Polymers 0.000 description 1
- 229920001194 natural rubber Polymers 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 229960001180 norfloxacin Drugs 0.000 description 1
- OGJPXUAPXNRGGI-UHFFFAOYSA-N norfloxacin Chemical compound C1=C2N(CC)C=C(C(O)=O)C(=O)C2=CC(F)=C1N1CCNCC1 OGJPXUAPXNRGGI-UHFFFAOYSA-N 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 208000024691 pancreas disease Diseases 0.000 description 1
- 229920013653 perfluoroalkoxyethylene Polymers 0.000 description 1
- 150000002989 phenols Chemical class 0.000 description 1
- YHHSONZFOIEMCP-UHFFFAOYSA-O phosphocholine Chemical compound C[N+](C)(C)CCOP(O)(O)=O YHHSONZFOIEMCP-UHFFFAOYSA-O 0.000 description 1
- 229920002493 poly(chlorotrifluoroethylene) Polymers 0.000 description 1
- 229920001495 poly(sodium acrylate) polymer Polymers 0.000 description 1
- 229920002401 polyacrylamide Polymers 0.000 description 1
- 239000004584 polyacrylic acid Substances 0.000 description 1
- 239000005023 polychlorotrifluoroethylene (PCTFE) polymer Substances 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 229920002338 polyhydroxyethylmethacrylate Polymers 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 229920001343 polytetrafluoroethylene Polymers 0.000 description 1
- 239000004810 polytetrafluoroethylene Substances 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 229920002981 polyvinylidene fluoride Polymers 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 230000002980 postoperative effect Effects 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 150000003856 quaternary ammonium compounds Chemical class 0.000 description 1
- 230000009257 reactivity Effects 0.000 description 1
- 229940100890 silver compound Drugs 0.000 description 1
- 150000003379 silver compounds Chemical class 0.000 description 1
- NNMHYFLPFNGQFZ-UHFFFAOYSA-M sodium polyacrylate Chemical compound [Na+].[O-]C(=O)C=C NNMHYFLPFNGQFZ-UHFFFAOYSA-M 0.000 description 1
- 230000006641 stabilisation Effects 0.000 description 1
- 238000011105 stabilization Methods 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 229920006132 styrene block copolymer Polymers 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 239000010409 thin film Substances 0.000 description 1
- 229960000790 thymol Drugs 0.000 description 1
- 238000002054 transplantation Methods 0.000 description 1
- 238000004383 yellowing Methods 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201611218049.X | 2016-12-26 | ||
| CN201611218049.XA CN108236751B (zh) | 2016-12-26 | 2016-12-26 | 一种双层引流管 |
| PCT/CN2017/105627 WO2018120982A1 (zh) | 2016-12-26 | 2017-10-11 | 一种双层引流管 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2020505187A JP2020505187A (ja) | 2020-02-20 |
| JP2020505187A5 true JP2020505187A5 (enExample) | 2020-04-02 |
Family
ID=62701317
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019555530A Pending JP2020505187A (ja) | 2016-12-26 | 2017-10-11 | 二層ドレナージチューブ |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20190314618A1 (enExample) |
| EP (1) | EP3560540A4 (enExample) |
| JP (1) | JP2020505187A (enExample) |
| CN (1) | CN108236751B (enExample) |
| WO (1) | WO2018120982A1 (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN109331327A (zh) * | 2018-09-05 | 2019-02-15 | 贵州千叶药品包装股份有限公司 | 一种双层预灌装阴道给药器及其制备方法 |
| CN109646790B (zh) * | 2018-12-14 | 2021-04-09 | 温州医科大学附属第一医院 | 一种双j管结构 |
| CN112657018A (zh) * | 2020-12-16 | 2021-04-16 | 南京康鼎新材料科技有限公司 | 尼龙挤出包覆的医用复合管材及具有其的注射管装置 |
| CN118526262A (zh) * | 2024-04-28 | 2024-08-23 | 东南大学 | 一种自控温热疗磁性水凝胶手动植入装置 |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5505717A (en) * | 1993-09-15 | 1996-04-09 | Moore; Patrick S. | Urinary drainage device |
| JPH1057496A (ja) * | 1996-06-14 | 1998-03-03 | Olympus Optical Co Ltd | 医療用留置チューブ |
| US5997517A (en) | 1997-01-27 | 1999-12-07 | Sts Biopolymers, Inc. | Bonding layers for medical device surface coatings |
| CN2531802Y (zh) * | 2001-07-19 | 2003-01-22 | 华中科技大学同济医学院附属同济医院 | T型组合胆道引流管 |
| JP2007000392A (ja) * | 2005-06-24 | 2007-01-11 | Kaneka Corp | カテーテルチューブ |
| CN1843516A (zh) | 2006-05-17 | 2006-10-11 | 朱定华 | T形引流管 |
| JP2010533562A (ja) * | 2007-07-16 | 2010-10-28 | シー．アール．バード，インコーポレイテッド | 滅菌バリヤを備えたフォリイ・カテーテル |
| US20100152698A1 (en) * | 2008-12-12 | 2010-06-17 | Cook Incorporated | Anti-thrombogenic catheter and method |
| AU2008347296A1 (en) * | 2008-01-04 | 2009-07-16 | C.R. Bard, Inc | Synthetic polyisoprene foley catheter |
| JP4981994B2 (ja) * | 2010-03-26 | 2012-07-25 | オリンパスメディカルシステムズ株式会社 | 医療用ステント |
| CN202961472U (zh) * | 2012-12-28 | 2013-06-05 | 王涛 | 双层引流管 |
| JP2014239742A (ja) * | 2013-06-11 | 2014-12-25 | ダイキン工業株式会社 | カテーテルチューブ |
| EP3035990B1 (en) * | 2013-08-23 | 2019-05-22 | Boston Scientific Scimed, Inc. | Catheters and catheter shafts |
| GB2532044A (en) * | 2014-11-06 | 2016-05-11 | Phagenesis Ltd | Catheter for recovery of dysphagia |
| CN204364203U (zh) * | 2015-01-07 | 2015-06-03 | 北京国械堂科技发展有限责任公司 | 粪便引流装置 |
| CN205411890U (zh) * | 2015-09-22 | 2016-08-03 | 江苏苏云医疗器材有限公司 | 一种鼻肠管 |
| CN105327437A (zh) * | 2015-11-19 | 2016-02-17 | 绍兴新原力科技有限公司 | 亲水型超滑导尿管及其制备方法 |
| CN207041728U (zh) * | 2016-12-26 | 2018-02-27 | 上海英诺伟医疗器械有限公司 | 一种双层引流管 |
-
2016
- 2016-12-26 CN CN201611218049.XA patent/CN108236751B/zh active Active
-
2017
- 2017-10-11 US US16/473,178 patent/US20190314618A1/en not_active Abandoned
- 2017-10-11 JP JP2019555530A patent/JP2020505187A/ja active Pending
- 2017-10-11 WO PCT/CN2017/105627 patent/WO2018120982A1/zh not_active Ceased
- 2017-10-11 EP EP17888214.8A patent/EP3560540A4/en not_active Withdrawn
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU650820B2 (en) | Nylon-peba copolymer catheter | |
| JP4991694B2 (ja) | 親水性を高め治療薬を送達するための新規な外表面積と貯留部を有するワイヤガイド | |
| JP2020505187A5 (enExample) | ||
| CN102202700B (zh) | 聚合材料 | |
| CN111132715B (zh) | 微导管 | |
| JP2020505187A (ja) | 二層ドレナージチューブ | |
| JP6619360B2 (ja) | 医療用具およびその製造方法 | |
| ES2765854T3 (es) | Recipiente biocompatible | |
| JP2003503163A (ja) | 使用者における人工ないし天然の導管を通じた膀胱のカテーテル法のためのアクセス部材およびシステム、並びに当該アクセス部材の取り換え方法 | |
| JP3631781B2 (ja) | 湿潤時に表面が潤滑性を有する医療用具 | |
| CN207401003U (zh) | 一种输尿管支架 | |
| CN106924864A (zh) | 一种超疏水疏油的抗反流输尿管支架 | |
| CN107952157B (zh) | 一种双层引流管 | |
| CN207041728U (zh) | 一种双层引流管 | |
| JPH0819599A (ja) | 湿潤時に表面が潤滑性を有する医療用具及びその製造方法 | |
| CN116209494B (zh) | 长条医疗器具及其制造方法 | |
| CN2572987Y (zh) | 外覆多层结构的医用介入导管 | |
| JPH04341836A (ja) | 鉗子チャンネル用可撓性チューブ及びその製造方法 | |
| JP3599784B2 (ja) | 湿潤時に表面が潤滑性を有する医療用具 | |
| JP2012161372A (ja) | 医療用具およびその製造方法 | |
| CN109529172A (zh) | 导管及导管组装体 | |
| JP3462903B2 (ja) | 湿潤時に表面が潤滑性を有する医療用具 | |
| JPH10216220A (ja) | 医療用具 | |
| WO2024209835A1 (ja) | バルーンカテーテル | |
| JP3580843B2 (ja) | 低摩擦性医療用具およびその製造方法 |